Related Experiment Video
Updated: Nov 29, 2025

Treatment of Ankle Osteoarthritis with Total Ankle Replacement Through a Lateral Transfibular Approach
Published on: January 24, 2018
Inpatient and outpatient opioid requirements after total joint replacement are strongly influenced by patient and
Austin J Roebke1, Garrhett G Via2, Joshua S Everhart3
1Department of Orthopaedics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Insights
Total knee arthroplasty (TKA) patients require more opioids post-surgery than total hip arthroplasty (THA) patients. Surgical factors and patient characteristics, not anesthesia or non-opioid drugs, predict opioid needs after joint replacement.
Area of Science:
- Orthopedic Surgery
- Pain Management
- Pharmacology
Background:
- Comprehensive national guidelines for analgesic strategies after total joint replacement are lacking.
- Understanding opioid requirements after total hip arthroplasty (THA) and total knee arthroplasty (TKA) is crucial for optimizing patient care.
- Identifying risk factors for increased inpatient and outpatient opioid use is essential for developing targeted pain management protocols.
Purpose of the Study:
- To compare inpatient and outpatient opioid requirements following THA versus TKA.
- To identify risk factors influencing opioid consumption after total hip or knee arthroplasty.
- To evaluate the impact of regional nerve blocks (RNB), neuraxial anesthesia (NA), and non-opioid medications on opioid demand.
Main Methods:
- Analysis of outcomes in 92 primary THA (n=43) and TKA (n=49) patients, excluding those with repeat surgery within 90 days.
- Recording of inpatient and 90-day postoperative opioid use, including total consumption, refills, and use beyond 90 days.
- Multivariate modeling to assess the influence of surgery type, anesthesia, non-opioid medications, demographics, length of stay, and baseline opioid use.
Main Results:
- TKA patients exhibited significantly higher daily inpatient opioid use (median 12.0 vs 7.0) and greater 90-day use (median 224.0 vs 100.5) compared to THA patients.
- TKA patients were more likely to require opioid refills (84% vs 33%) and had a higher risk of use beyond 90 days (adjusted OR 7.64).
- Inpatient opioid use 24 hours before discharge was the strongest predictor of 90-day opioid use; surgical procedure, demographics, and baseline use were more influential than anesthesia or non-opioid analgesics.
Conclusions:
- Opioid use following TKA and THA is primarily predicted by surgical and patient-specific factors.
- Total knee arthroplasty is associated with substantially higher postoperative opioid requirements than total hip arthroplasty.
- Regional nerve blocks, neuraxial anesthesia, and common non-opioid medications did not significantly reduce total inpatient or 90-day postoperative opioid consumption.
Aims:
Currently, there is no single, comprehensive national guideline for analgesic strategies for total joint replacement. We compared inpatient and outpatient opioid requirements following total hip arthroplasty (THA) versus total knee arthroplasty (TKA) in order to determine risk factors for increased inpatient and outpatient opioid requirements following total hip or knee arthroplasty.
Methods:
Outcomes after 92 primary total knee (n = 49) and hip (n = 43) arthroplasties were analyzed. Patients with repeat surgery within 90 days were excluded. Opioid use was recorded while inpatient and 90 days postoperatively. Outcomes included total opioid use, refills, use beyond 90 days, and unplanned clinical encounters for uncontrolled pain. Multivariate modelling determined the effect of surgery, regional nerve block (RNB) or neuraxial anesthesia (NA), and non-opioid medications after adjusting for demographics, ength of stay, and baseline opioid use.
Results:
TKAs had higher daily inpatient opioid use than THAs (in 5 mg oxycodone pill equivalents: median 12.0 vs 7.0; p < 0.001), and greater 90 day use (median 224.0 vs 100.5; p < 0.001). Opioid refills were more likely in TKA (84% vs 33%; p < 0.001). Patient who underwent TKA had higher independent risk of opioid use beyond 90 days than THA (adjusted OR 7.64; 95% SE 1.23 to 47.5; p = 0.01). Inpatient opioid use 24 hours before discharge was the strongest independent predictor of 90-day opioid use (p < 0.001). Surgical procedure, demographics, and baseline opioid use have greater influence on in/outpatient opioid demand than RNB, NA, or non-opioid analgesics.
Conclusion:
Opioid use following TKA and THA is most strongly predicted by surgical and patient factors. TKA was associated with higher postoperative opioid requirements than THA. RNB and NA did not diminish total inpatient or 90-day postoperative opioid consumption. The use of acetaminophen, gabapentin, or NSAIDs did not significantly alter inpatient opioid requirements.Cite this article: Bone Joint Open 2020;1-7:398-404.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Drug Dosing: Obese Patients
Opioid Receptors: Overview
